|
|
||||||||
MUSCLE CELL BIOLOGY AND CELL MOTILITY
1Department of Movement Sciences, University of Illinois at Chicago, Chicago, Illinois; and 2Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan
Submitted 17 November 2004 ; accepted in final form 11 February 2005
Skeletal muscle possesses a remarkable capacity for regeneration. Although the regulation of this process at the molecular level remains largely undefined, the plasminogen system appears to play a critical role. Specifically, mice deficient in either urokinase-type plasminogen activator (uPA/ mice) or plasminogen demonstrate markedly impaired muscle regeneration after injury. In the present study, we tested the hypothesis that loss of the primary inhibitor of uPA, plasminogen activator inhibitor-1 (PAI-1), would improve muscle regeneration. Repair of the extensor digitorum longus muscle was assessed after cardiotoxin injury in wild-type, uPA/, and PAI-1-deficient (PAI-1/) mice. As expected, there was no uPA activity in the injured muscles of uPA/ mice, and muscles from these transgenic animals demonstrated impaired regeneration. On the other hand, uPA activity was increased in injured muscle from PAI-1/ mice to a greater extent than in wild-type controls. Furthermore, PAI-1/ mice demonstrated increased expression of MyoD and developmental myosin after injury as well as accelerated recovery of muscle morphology, protein levels, and muscle force compared with wild-type animals. The injured muscles of PAI-1-null mice also demonstrated increased macrophage accumulation, contrasting with impaired macrophage accumulation in uPA-deficient mice. The extent of macrophage accumulation correlated with both the clearance of protein after injury and the efficiency of regeneration. Taken together, these results indicate that PAI-1 deficiency promotes muscle regeneration, and this protease inhibitor represents a therapeutic target for enhancing muscle regeneration.
muscle injury; muscle repair; urokinase-type plasminogen activator; muscle inflammation; macrophage
This article has been cited by other articles:
![]() |
M. Cheng, M.-H. Nguyen, G. Fantuzzi, and T. J. Koh Endogenous interferon-{gamma} is required for efficient skeletal muscle regeneration Am J Physiol Cell Physiol, May 1, 2008; 294(5): C1183 - C1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. DiPasquale, M. Cheng, W. Billich, S. A. Huang, N. van Rooijen, T. A. Hornberger, and T. J. Koh Urokinase-type plasminogen activator and macrophages are required for skeletal muscle hypertrophy in mice Am J Physiol Cell Physiol, October 1, 2007; 293(4): C1278 - C1285. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suelves, B. Vidal, A. L. Serrano, M. Tjwa, J. Roma, R. Lopez-Alemany, A. Luttun, M. M. de Lagran, M. A. Diaz, M. Jardi, et al. uPA deficiency exacerbates muscular dystrophy in MDX mice J. Cell Biol., September 7, 2007; 178(6): 1039 - 1051. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Bryer and T. J. Koh The urokinase-type plasminogen activator receptor is not required for skeletal muscle inflammation or regeneration Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1152 - R1158. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |